Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beraprost Na for Endothelial Dysfunction in Type 2 Diabetes
NCT01061060Phase 4Completed
- Sponsor
- Yonsei University
- Start
- Jan 2010
- Primary completion
- Oct 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Peripheral microvascular disease (MVD) comparing Beraprost group with Placebo group (2 arms). Primary endpoint: Symptomatic improvement by Total Symptom Score (TSS) at 8 weeks. Started Jan 2010; status: completed.
02
Drugs
beraprost
03
Conditions
Peripheral microvascular disease (MVD)
Beyond the preview
Go deeper on NCT01061060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01061060.